|
|
Latest Headlines
Xcelience and IriSys business alliance agreement strengthens regional access to CMC/Regulatory expertise
 More...
| Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area
More...
| Xcelience and Penn Pharma Form a Joint Venture to Provide API Into Capsule Services in Europe and Asia Pacific Markets
More...
|
|
|
|
|
|
|
Case Studies
|
|
|
|
Case Study 2
Formulation of an Insoluble Compound with Poor Bioavailability
|
|
Sponsor requested a set of 3 formulations to enhance bioavailability of an NME within a 6 week timeframe for animal pharmacology studies.
|
|
Drug product methods were developed and a set of oil in water self micro-emulsifying concentrates were prepared.
|
|
These formulations were found to be chemically and physically stable.
|
|
This improved bioavailability enabled the client to increase animal exposure.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|